key: cord-0785526-cjhycfap
authors: Shearer, Freya M.; Walker, James; Tellioglu, Nefel; McCaw, James M.; McVernon, Jodie; Black, Andrew; Geard, Nicholas
title: Rapid assessment of the risk of SARS-CoV-2 importation to Australia in February 2020
date: 2022-02-24
journal: Epidemics
DOI: 10.1016/j.epidem.2022.100549
sha: 5bf585adb9baab3b9f72c7cfd195f97ad9bab106
doc_id: 785526
cord_uid: cjhycfap

During the early stages of an emerging disease outbreak, governments are required to make critical decisions on how to respond, despite limited data being available to inform these decisions. Analytical risk assessment is a valuable approach to guide decision-making on travel restrictions and border measures during the early phase of an outbreak. Here we describe a rapid risk assessment framework that was developed in February 2020 to support time-critical decisions on the risk of SARS-CoV-2 importation into Australia. We briefly describe the context in which our framework was developed, the framework itself, and provide an example of the type of decision support provided to the Australian government. We then report a critical evaluation of the modelling choices made in February 2020, assessing the impact of our assumptions on estimated rates of importation, and provide a summary of “lessons learned”. The framework presented and evaluated here provides a flexible approach to rapid assessment of importation risk, of relevance to current and future pandemic scenarios.

potentially scarce testing resources are used; and finally, the possibility of restricting travel. 23 Each of these may be applied in a targeted fashion based on the country in which travel origi-24 nated. 25 For a previously uncharacterised pathogen, these decisions are hampered by at least two 26 key sources of uncertainty. The first is the natural history of a novel pathogen may be poorly 27 understood, including factors such as the duration of latent and infectious periods, and the 28 relationship between infectiousness and symptoms. The second is the effectiveness and capacity 29 of health and political systems in different countries, in particular with respect to their ability 30 J o u r n a l P r e -p r o o f Journal Pre-proof 2.2 Rapid risk assessment framework 75 We introduce a modular framework for assessing the risk of SARS-CoV-2 being imported from 76 a source country (here China) to a country of interest (here Australia) via other intermediary 77 countries in the region. The framework was developed very rapidly to provide a rational basis 78 for decision-making on border measures and case definitions in Australia at a time when global 79 transmission of SARS-CoV-2 was not yet established. In developing this framework, we were 80 asked to focus on the risk of (potentially undetected) spread to countries in the South East Asia 81 and Western Pacific regions because they are highly connected to both China and Australia, 82 relative to the rest of the world. Our analysis takes into account the COVID-19 epidemiological 83 situation and mobility restrictions imposed as of mid-February but is adaptable to other contexts 84 for future outbreak response. 85 The framework includes a series of analyses based on epidemiological evidence at the time, 86 patterns of air travel, and model components described by De Salazar and colleagues [13] and 87 developed by the authors. Our framework considered a single point of origin for all exported 88 infections, as China was the only country reporting uncontained transmission at the time of 89 analysis. Each step of the analysis is outlined in Figure 1 and described in more detail below. Probability of an outbreak Outbreak size Importation risk to Australia

Step 1

Step 2

Step 3

Step 5

Step 4

Intermediary countries (SEA and WP regions) Country of interest (Australia) Figure 1 : Key quantity estimated at each step of the full analysis of SARS-CoV-2 importation risk to Australia (country of interest) via countries in the South East Asia and Western Pacific regions (intermediary countries), given travel restrictions from mainland China (source country) (top). A brief indication of the relevant data and/or method used at each step (bottom).

Step 1: Importation risk from China to intermediary countries Step 2: Number of potentially undetected cases in intermediary countries

The number of potentially undetected introductions in each intermediary country was based 104 on the discrepancy between expected (Step 1) and reported cases (noting that cases due to 105 local transmission were excluded from these counts). Under the assumption that all reported 106 cases were effectively isolated (24 hours after symptom onset) with reduced risk to onward 107 transmission, the difference between the expected and reported numbers of cases per country 108 provided a crude estimate of the number of unreported cases. We assumed unreported cases 109 were undetected and therefore more likely to contribute to local transmission and potentially a 110 large outbreak.

Step 3: Probability of an outbreak in intermediary countries 112 A branching process model was used to generate stochastic projections of the initial stages of 113 an outbreak for each country. This model incorporates country-specific rates of SARS-CoV-2 114 importation (as estimated in Step 1) and country-specific detection probabilities based on the 115 ratio of reported cases to expected cases (with a maximum detection probability of 1). We 116 assumed an R 0 of 2.68 (within the range estimated for SARS-CoV-2 in Wuhan in early January

[11]), no individual-level variation in transmission and independence of all undetected introduc-118 tions [1] . The probability of local transmission was defined as the proportion of simulations 119 with no locally transmitted cases five weeks after simulation commenced (i.e., 26 February).

The model assumes individuals can be either Exposed (E), Infectious (I), Recovered (R), 122 or isolated (V ). The exposed and infectious classes are split into two compartments (giving 123 them an Phase-type distribution) and symptom onset is taken to correspond to the transition 124 between exposed and infectious states (see Figure 2 ).

I 2 E 1 imports cases created by local transmission p(t) Figure 2 : The Susceptible, Exposed, Infected, Recovered model with isolation and external importation of cases. The average duration of time spent in each state is indicated over the circles. The class V represents isolated cases that can no longer transmit.

Imported cases are assumed to be in the first exposed class. At the time on symptom onset 126 there is a probability, p(t), that the individual is detected (either from direct contact tracing 127 efforts or enhanced case finding) and hence with probability 1 − p(t), the case is missed. This 128 probability depends on the current public health system workload and hence time. Once the 129 case is detected there is a 24-hour period before they are completely isolated during which it is 130 possible for them to infect others.

The probability of detection is related to the workload,

J o u r n a l P r e -p r o o f Journal Pre-proof where p 0 is the baseline probability of detection and w c is the workload capacity. So while the 133 workload is less than the capacity, the probability of detection remains high, but decreases once 134 the capacity is exceeded.

For each country, the import rate is calculated as the weighted mean of daily expected cases, 136 with weights set according to the time intervals between data points. The initial detection 137 probability (p 0 ) of each country was calculated as the mean of the ratio of cumulative reported 138 cases to the cumulative expected cases starting from 29 January. The maximum value of p 0 was 139 1.0. The public health system workload capacity w c , used for updating the detection probability, 140 was conservatively set to 10 detected infections per day.

Step 4: Estimated size of an uncontained outbreak in intermediary countries 142 The stochastic transmission model described in

Step 3 was also used to estimate the likely 143 number of locally transmitted cases in each intermediary country, conditional on local trans-144 mission occurring. This model assumed no public health intervention (beyond case isolation), 145 and that both importation rate and detection probability were constant over time. The trans-146 mission model was run from 22 January, with epidemic curves (separated by imports and local 147 transmission) projected forward by one week beyond the last data collection date (19 February).

Step 5: Importation risk from intermediary countries to a country of interest 149 The likelihood that a passenger arriving in Australia from a country in the South East Asia 150 or Western Pacific region would be infected by SARS-CoV-2 was then estimated based on the 151 likely source prevalence in a particular country, and the travel volume from that country to 152 Australia. Samples of the estimated epidemic state of each intermediary country (from Step 153 4) were used to set a rate of importation of exposed individuals, where the rate of importation 154 is the product of the number of exposed individuals in the country and the rate of travel 155 from the country, divided by the country population size. We assumed that prevalence in each 156 country was growing exponentially with a doubling time of seven days; hence imports from each 157 country grew exponentially. Accordingly, we modelled the importation times into Australia as 158 an inhomogeneous Poisson process. The doubling time of seven days was consistent with early 159 estimates [11, 14] . We then computed the expected number of imported infections per day into 160 Australia, and here we report the date that this number exceeded a seven-day moving average 161 of five per day.

Travel volumes from countries within the South East Asia and Western Pacific regions to 163 Australia were extracted from the Australian Bureau of Statistics [12, 15] . February 2020. At this time, the only country reporting uncontained/sustained transmission was China and restrictions to travellers from mainland China to Australia were imposed. Relative risks are indicated by colour shading, with red representing the highest risk and green the lowest. Note that for efficiency, this rapid analysis used the limited case data provided in World Health Organization situation reports. We did not make use of more detailed local data available from individual country health agencies, and therefore these analyses may not have reflected the epidemiological situation in each location at the time.

expected, and hence a higher estimated number of undetected cases (Figure 4 ), leading to pro-176 jection of considerable undetected local transmission. In contrast, Malaysia and Singapore both 177 reported a number of cases equal to or greater than expected, and hence have a lower estimated 178 number of undetected cases, leading to projection of more modest levels of local transmission.

Note that the projected levels of local transmission in Singapore are lower than the actual re-180 ported local cases. These known local cases were not further incorporated into our analysis, 181 but rather signalled to decision makers that the likelihood of further undetected transmission 182 was relatively low. Furthermore, for efficiency, our rapid analysis used the limited case data 183 provided in World Health Organization situation reports. We did not make use of more detailed 184 local data available from individual country health agencies and therefore our analyses may not 185 have reflected the epidemiological situation in each location at the time. onset of infectiousness to isolation of detected cases, on our risk assessment outcome. Table 1 256 shows the mean duration in days of latent, pre-symptomatic infectious, infectious and effective Our branching process model also incorporates a parameter for public health system work-263 load capacity. For the rapid risk assessment conducted in February, this parameter was set to a 264 conservative 10 detected infections per day. Here we explored the impact of increasing workload 265 capacity to 20, 50, and 100 detected infections per day on the rate of importation into Australia. Table 2 . The baseline model used in our rapid risk assessment in February 2020 estimated that the We developed a framework to assess the importation risk of SARS-CoV-2 into Australia during 295 the early phase of the epidemic, from late January to mid-February 2020. The dominant 296 importation risk to Australia at the time of analysis was directly from China, as the only country 297 reporting uncontained transmission. With travel restrictions from mainland China to Australia 298 imposed from 1 February 2020, our framework was designed to consider the importation risk 299 from China (source country) into Australia (country of interest) via potential intermediary 300 countries. We focused on countries in the South East Asia and Western Pacific regions as 301 potential intermediary countries since they are highly connected to both China and Australia, 302 relative to the rest of the world.

The primary output of our framework was a risk table (Figure 3 ) that was updated and 

Our initial analysis focused on identifying undetected epidemics rather than modelling ob-317 served epidemics (other than in the source country). Thus from late February, the risk appraisal 318 shifted focus to observed case data from many countries, leading to the imposition of travel re-319 strictions on specific countries and culminating in a blanket travel ban on 19 March 2020.

In November 2020, we revisited our original analysis to evaluate the impact of model as- 

In the remainder of this discussion, we summarise strengths and limitations of our frame-333 work, and lessons learned for future rapid-response efforts (Table 3) . While these lessons are 334 supported by our experience with the framework described here, we believe they are more 335 generally applicable to policy-engaged modelling.

A key strength of our approach is its transparency with respect to both individual factors Separately reporting the individual factors contributing to importation risk, while increasing the size and complexity of the risk tables, enabled decision-makers to incorporate their own expertise in interpreting estimates.

The simplicity of each individual component of the framework, while requiring abstraction of a more complex reality, was critical for its rapid development and deployment. The simplicity of the overall framework also made it relatively straightforward to explain to decision-makers how risk estimates had been arrived at. Eventually, this simplicity was also a limitation, as the framework was not equipped to incorporate emerging empirical data on local transmission in intermediary countries. The constrained focus on the Asia-Pacific region also proved to be a limitation when it emerged that transmission, and hence sources of importation to Australia, were more widespread than initially thought.

Decoupling the calculations involved in each component of the framework enabled specific sub-models to be substituted without extensive modification of other components. As exemplified in the critical evaluation reported here, this decoupling also allowed ready comparison of the impact of alternative sub-models. While this modular approach allowed incorporation of existing models-for example, for estimating undetected cases [13]that did also entail accepting limitations of those models, such as specific assumptions around baseline case-detection capacity.

The use of stochastic models in several components of the framework (estimating undetected cases and local epidemic growth) enabled quantification of uncertainty around risk estimates. Conveying this uncertainty to decision-makers was critical as there was considerable uncertainty about key epidemiological parameters for COVID-19 during this period. A key omission of our initial analysis was the over-dispersion of secondary cases, which proved to be both an important characteristic of COVID-19 transmission, and a factor to which our risk estimates were particularly sensitive.

One of the most time-consuming aspects of developing and applying the analytical framework involved locating and processing relevant data sources on mobility, policy response, epidemiology, and so on. As has been recognised elsewhere [20] , streamlining the consolidation, standardising and sharing of epidemiological data will play a vital role on supporting rapidresponse analysis in the event of future pandemics.

Decision-making in the early stages of a pandemic is time-critical. Using this framework to produce initial risk estimates within days of request provided a foundation for subsequent engagement. These initial estimates were then extended and refined with the addition of emerging data and methods. At the other end of the life-cycle, transparency around the limitations of the framework enabled a transition to risk forecasts based on emerging epidemiological data both internationally and locally.

J o u r n a l P r e -p r o o f Journal Pre-proof our approach are still possible and valuable. In addition, each analysis component has modest data requirements and low computation cost, making rapid preliminary assessment across a 343 range of countries feasible. As the outbreak progressed, mismatches between model projections 344 and observed epidemiology could be readily observed and incorporated into decision making.

A strength of our modular approach is that it enables individual components to be adapted 346 as new data and models become available, or as information needs change in response to the 347 evolving situation. The breakdown of our workflow (Figure 1) to the country of interest, components of the analysis, specifically Steps 1 and 2, would need to 381 be adapted to account for high levels of known local transmission in countries other than the 382 initial source country. The current motivation for developing the framework in this direction is 383 the need to assess the risk of importation in the context of proposed "travel bubbles" between 384 countries with very low or no community transmission.

When developing the framework in February 2020, we faced a trade-off between the need for a 386 general approach that could be rapidly applied to a wide range of countries and a more complex 387 approach that could make use of richer data in a subset of those countries. Incorporating 388 methods that can better account for heterogeneous data quality would enable the use of more assumptions about global epidemiology and health system capacity, due to limitations in both 392 time and data, constraining its relevance to a specific phase of the early COVID-19 pandemic.

The framework we have developed provides a risk assessment from solely from an epidemio-394 logical perspective. It does not consider the potential social, political and economic implications 395 of future border measures and mobility restrictions which are both substantial [24] and will exert 396 an influence on epidemiology as people change their behaviour [25] . This framework is therefore 397 only one key element to be considered by decision-makers contemplating possible border policies 398 and mobility restrictions, which are ultimately a political determination.

In conclusion, by developing a modular framework that describes not only the underlying Rapid-response modelling analyses will continue to be an essential input to emergency out-408 break decision-making. Using existing frameworks enables researchers to rapidly pull together 409 the available data in order to provide timely advice that reflects uncertainties, and is communi-410 cated in a transparent and effective manner. Additionally, retrospective, documented evaluation 411 of these frameworks is critical to their improvement and utility for future outbreak response.

The effect of travel restrictions on the spread of the 2019 novel coronavirus 417 (COVID-19) outbreak. Science

Assessing spread risk of Wuhan novel 420 coronavirus within and beyond China

Preparedness 425 and vulnerability of African countries against importations of COVID-19: a modelling 426 study

Epidemic and intervention modelling: a scientific 428 rationale for policy decisions? lessons from the 2009 influenza pandemic

Perspectives on model forecasts of the 2014-2015 ebola epidemic in west africa: 432 Lessons and the way forward

World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report -1. Avail-434 able at

World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report -22. Avail-437 able at

World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report -22. Avail-440 able at

Australian Government Department of Health. 2019-nCoV acute respiratory disease, Aus-443 tralia

Australian Government Department of Health. Australian Health Protection Principal 445

Committee (AHPPC) novel coronavirus statement on 1

Nowcasting and forecasting the poten-448 tial domestic and international spread of the 2019-nCoV outbreak originating in Wuhan

China: a modelling study

Overseas Arrivals and Departures, Australia. 'Table 5

Short-term Movement, Visitors Arriving -Selected Countries of Residence: Original', time 453 series spreadsheet

DetailsPage/3401.0Nov%202019?OpenDocument

Identifying 456 locations with possible undetected imported severe acute respiratory syndrome coronavirus 457 2 cases by using importation predictions

Xuesen Xing, Nijuan Xiang

Early transmission 466 dynamics in wuhan, china, of novel coronavirus-infected pneumonia

Overseas Arrivals and Departures, Australia. 'Table 10

Short-term Movement, Residents Returning -Length of Stay and Main Reason for Jour-470 ney: Original', time series spreadsheet

AUSSTATS/abs@.nsf/DetailsPage/3401.0Nov%202019?OpenDocument

Early analysis of the australian covid-19 epidemic

Estimating the number of undetected COVID-19 cases 482 among travellers from mainland China

Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Work-490 ing Group

Monitoring key epidemiological parameters of sars-cov-2 transmission

Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts

Quantifying bias of 502

COVID-19 prevalence and severity estimates in Wuhan, China that depend on reported 503 cases in international travelers. medRxiv

An integrative review of the 508 limited evidence on international travel bans as an emerging infectious disease disaster 509 control measure

Nine challenges in incorporating the dynamics of 512 behaviour in infectious diseases models